logo

ADMA

ADMA Biologics·NASDAQ
--
--(--)
--
--(--)
Latest data update time: Updated on 2026-02-07
3.83 / 10Overall Score
NeturalInvestment Rating
FundamentalSentimentTechnical
Should I Buy ADMA Now?
  • Based on a composite score of 3.83/10, we rate ADMA as a Netural. Our analysis breaks down into 2.75/10 for Fundamentals, 4.83/10 for Technicals, and 3.86/10 for Sentiment, indicating the stock is likely to consolidate sideways.
Is ADMA fundamentally strong?
What is the current technical signals for ADMA?
What is the market sentiment for ADMA?